Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta®Mice treated with 5,9-dimethyldibenzo[c,g]carbazole

Carcinogenesis

Volumn 20, Issue 1, 1999, Pages 125-132

  Tombolan, Françoise ^a,b   Renault, Dominique ^a   Brault, Dominique ^a   Guffroy, Magali ^a   Perin Roussel, Odette ^c   Périn, François ^c   Thybaud, Veronique ^a  

^a SANOFI   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,9 DIMETHYLDIBENZO[C,G]CARBAZOLE; BETA GALACTOSIDASE; CARBAZOLE DERIVATIVE; CARCINOGEN; DNA; PHOSPHORUS 32; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; GENE MUTATION; ISOTOPE LABELING; KINETICS; LIVER; LIVER CARCINOGENESIS; LIVER CELL; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CARBAZOLES; CARCINOGENS; CELL DIVISION; CELL NUCLEUS; DNA ADDUCTS; DNA REPLICATION; LAC OPERON; LIVER; MALE; MICE; MICE, TRANSGENIC; MUTAGENESIS;

EID: 0032921794     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.1.125     Document Type: Article

References (48)

1. IARC (1972) Certain polycyclic aromatic hydrocarbons and heterocyclic compounds. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. IARC Science Publications No. 3, IARC, Lyon, pp. 260-268.
2. Périn, F., Valéro, D., Mispelter, J. and Zajdela, F. (1984) In vitro metabolism of N-methyl-dibenzo[c,g]carbazole, a potent sarcomatogen devoid of hepatotoxic and hepatocarcinogenic properties. Chem. Biol. Interact., 48, 281-295.
3. Valéro, D., Périn, F., Plessis, M.J. and Zajdela, F. (1985) Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzo[c,g]carbazole induced hepatocarcinogenesis in mouse. Cancer Lett., 27, 181-187.
4. Valéro, D., Périn, F. and Zajdela, F. (1983) Binding of 5,9-dimethyl-dibenzo[c,g]carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins. Carcinogenesis, 4, 1333-1340.
5. Szafarz, D., Valéro, D., Périn, F. and Bornecque, C. (1990) Effect of partial hepatectomy on the formation and elimination of 3-methyl-dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole-DNA adducts in mouse liver. Biol. Cell., 68, 91-94.
6. Périn-Roussel, O., Périn, F., Barat, N., Plessis, M.J. and Zajdela, F. (1995) Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivatives with hepatic mitochondrial and nuclear DNA in the mouse. Environ. Mol. Mutagen., 25, 202-210.
7. Périn, F., Valéro, D., Thybaud-Lambay, V., Plessis, M.J. and Zajdela, F. (1988) Organ-specific, carcinogenic dibenzo[c,g]carbazole derivatives: discriminative response in S.typhimurium TA100 mutagenesis modulated by subcellular fractions of mouse liver. Mutat. Res., 198, 15-26.
8. Gossen, J.A., DeLeeuw, W.J.F., Tan, C.H.T., Zwarthoff, E.C., Berends, F., Lohman, P.H.M., Knook, D.L. and Vijg, J. (1989) Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl Acad. Sci. USA, 86, 7971-7975.
9. Swiger, R.R., Myrh, B. and Tucker, J.D. (1994) The lacZ transgene in Muta™Mouse maps to chromosome 3. Mutat. Res., 325, 145-148.
10. - plasmids. Nucleic Acids Res., 20, 3254.
11. Brault, D., Bouilly, C., Renault, D. and Thybaud, V. (1996) Tissue-specific induction of mutations by acute oral administration of N-methyl-N′-nitro-N-nitrosoguanidine and β-propiolactone to the Muta™Mouse: preliminary data on stomach, liver and bone marrow. Mutat. Res., 360, 83-87.
12. Renault, D., Brault, D. and Thybaud, V. (1997) Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta™Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa). Mutat. Res., 388, 145-153.
13. Dean, S.W. and Myrh, B. (1994) Measurement of gene mutations in vivo using Muta™Mouse and positive selection for lacZ-phage. Mutagenesis, 9, 183-185.
14. Callahan, J.D. and Short, J.M. (1995) Transgenic 1/lacI mutagenicity assay: statistical determination of sample size. Mutat. Res., 327, 201-208.
15. Gupta, R.C. (1984) Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl Acad. Sci. USA, 81, 6943-6947.
16. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
17. Périn-Roussel, O., Barat, N., Zajdela, F. and Périn, F. (1997) Tissue-specific differences in adduct formation by hepatocarcinogenic and sarcomatogenic derivatives of 7H-dibenzo[c,g]carbazole in mouse parenchymal and nonparenchymal liver. Environ. Mol. Mutagen., 29, 346-356.
18. Fung, K.Y., Douglas, G.R. and Kewsky, D. (1998) Statistical analysis of lacZ mutant frequency data from Muta™Mouse mutagenicity assays. Mutagenesis, 13, 249-255.
19. Hakura, A., Tsutsui, Y., Sonoda, J., Kai J., Imade, T. Shimada, M., Sugihara, Y. and Mikami, T. (1998) Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse). Mutat. Res., 398, 123-130.
20. Sisk, S.C., Pluta, L.J., Bond, J.A. and Recio, L. (1994) Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis, 15, 471-477.
21. - transgenic mutation assay to DMN: comparisons with the corresponding Big Blue® (lacI) responses. Mutat. Res., 307, 169-173.
22. Piegorsch, W.W., Lockhart, A.C., Carr, G.J. et al. (1997) Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: an interlaboratory study. Mutat. Res., 388, 249-289.
23. Nebert, D.W. (1989) The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol., 20, 153-174.
24. Okada, N., Honda, A., Kawabata, M. and Yajima, N. (1997) Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine. Mutagenesis, 12, 179-184.
25. Brooks, T.M., Szegedi, M., Rosher, P. and Dean, S.W. (1995) The detection of gene mutation in transgenic mice (Muta™Mouse) following a single oral dose of 2-acetylaminofluorene. Mutagenesis, 10, 149-150.
26. Mirsalis, J., Provost, G.S., Mathews, C., Hamner, R., Schindler, J.E., O'Loughlin, K., MacGregor, J.T. and Short, J.M. (1993) Induction of hepatic mutations in lacI transgenic mice. Mutagenesis, 8, 265-271.
27. Butterworth, B.E., Loury, D. and Smith-Oliver, T. (1985) The value of measurement of both genotoxicity and forced cell proliferation in assessing the potential carcinogenicity of chemicals. Proceedings of the Fourth International Conference on Environmental Mutagens, 214.
28. Preston-Martin, S., Pike, M.C., Ross, R.K., Jones, P.A. and Henderson, B.E. (1990) Increased cell division as a cause of human cancer. Cancer Res., 50, 7415-7421.
29. Ames, B.N. and Gold, L.S. (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science, 249, 970-971.
30. Hughes, P.E. and Pilzyk, R. (1970) The in vivo binding of metabolites of 2-naphthylamine to mouse liver DNA, RNA and protein. Chem. Biol. Interact, 1, 307-314.
31. Carthew, P., Martin, E.A. White, I.N.H., DeMatteis, F., Edwards, R.E., Dorman, B.M., Heydon, R.T. and Smith, L.L. (1995) Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital. Cancer Res., 55, 544-547.
32. 32P-Postlabeling analysis of DNA-adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis, 6, 1117-1126.
33. Hayward, J.J., Shane, B.S., Tindall, K.R. and Cunningham, M.L. (1995) Differential in vivo mutagenicity of the carcinogen/noncarcinogen pair 2,4-and 2,6-diaminotoluene. Carcinogenesis, 16, 2429-2433.
34. Shane, B.S., Wood, V.J., Cunningham, M.L. and Tindall, K.R. (1995) Effect of partial hepatectomy on the mutant frequency of lacI in Big Blue® mice treated with N-ethyl-N-nitrosourea. Environ. Mol. Mutagen., 25 (Suppl. 25), 47.
35. Krebs, O., Schäfer, B., Wolff, T., Oesterle, D., Deml, E., Sund, M. and Favor, J. (1998) The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue® transgenic F344 rats. Carcinogenesis, 19, 241-245.
36. Jackson, M.R. (1974) The nature of dimethylnitrosamine induced enlargement of rat hepatocyte nuclei. J. Pathol., 113, 197-208.
37. Neal, G.E., Judah, J.J. and Butler, W.H. (1976) Some effects of acute and chronic dosing with aflatoxin B1 on rat liver nuclei. Cancer Res., 86, 1771-1778.
38. Clawson, G.A., Blankenship, L.J., Rhame, J.G. and Wilkinson, D.S. (1992) Nuclear enlargement induced by hepatocarcinogens alters ploidy. Cancer Res., 52, 1304-1308.
39. Bortner, D.M. and Rosenberg, M.P. (1995) Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Diff., 6, 1579-1589.
40. Madra, S., Styles, J. and Smith, A.G. (1995) Perturbation of hepatocyte nuclear populations induced by iron and polychlorinated biphenyls in C57BL/10ScSn mice during carcinogenesis. Carcinogenesis, 16, 719-727.
41. Brodskii, V.I. (1985) Genome multiplication in growth and development: biology of polyploid and polytene cells. In Brodsky, V.Y. and Uryvaeva, I.V. (eds) Developmental and Cell Biology, Series 15. Cambridge University Press, Cambridge, UK.
42. Kung, A.L., Sherwood, S.W. and Schimke, R.T. (1990) Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl Acad. Sci. USA, 87, 9553-9557.
43. Yamada, K. and Kimmura, G. (1895) Formation of proliferative tetraploid cells after treatment of diploid cells with sodium butyrate in rat 3Y1 fibroblasts. J. Cell. Physiol., 122, 59-63.
44. Yoshida, M., Horinouchi, S. and Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of historic acetylation in chromatin structure and function. Bioessays, 221, 227-236.
45. Ishida, R., Sato, M., Narita, T., Utsumi, K.R., Nishimoto, T., Morita, T., Nagata, H. and Andoh, T. (1994) Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J. Cell Biol., 126, 1341-1351.
46. Usui, T., Yoshida, M., Abe, K., Osada, H., Isono, K. and Beppu, T. (1991) Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor K-252a. J. Cell Biol., 115, 1275-1282.
47. cdc2 phosphorylation sites in NuMA impair the assembly of the mitotic spindle and block mitosis. J. Cell Sci., 108, 621-633.
48. Sawin, K.E. and Mitchison, T.J. (1995) Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc. Natl Acad. Sci. USA, 92, 4289-4293.